With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Identifying Epigenetic Mechanisms Impacting Neuroblastoma Genome Stability and Drug Response||Massachusetts General Hospital / Johnathan Whetstine, PhD||Innovation Grants||2015||Massachusetts|
|Integrative Genomic and Immunogenomic Analysis of Neuroblastoma||University of California at Santa Cruz / David Haussler, PhD||Innovation Grants||2015||California|
|Developing a Novel Tumor Model to Screen for New Therapies for Spinal Ependymoma||The Johns Hopkins University School of Medicine / Linda Resar, MD & Richard Schlegel, MD, PhD||Innovation Grants||2015||Maryland|
|High-dimensional Biochemical CyTOF Analysis of Pediatric T cell Leukemias||University of California San Francisco / Jeroen Roose, PhD||Innovation Grants||2015||California|
|Enhanced Drug Repurposing Screen in DSRCT Enabled by New In Vitro and In Vivo Models Based on CRISPR/Cas9 Genome Engineering||Memorial Sloan-Kettering Cancer Center / Marc Ladanyi, MD & Maria Jasin, PhD||Innovation Grants||2015||New York|
|Characterizing Resistance Mechanisms to BET-Bromodomain Inhibition in MYC-amplified||Broad Institute / Rameen Beroukhim, MD,PhD||Innovation Grants||2015||Massachusetts|
|Identifying Mechanisms of Glucocorticoid Resistance in Pediatric Acute Lymphoblastic||University of Massachusetts Medical School / Michelle Kelliher, PhD||Innovation Grants||2015||Massachusetts|
|Small Molecule Inhibitors of ERG for Pediatric Leukemia and Sarcoma||University of Virginia, School of Medicine / John Bushweller, PhD||Innovation Grants||2015||Virginia|
|Regulation of Tumor Debris Mediated Inflammation as a Therapeutic Modality in Medulloblastoma||Dana-Farber Cancer Institute / Mark Kieran, MD, PhD & Dipak Panigrahy, MD||Innovation Grants||2015||Massachusetts|
|Enhancing Effectiveness of Immune Checkpoint Therapy in Neuroblastoma||Children's Hospital Los Angeles / Shahab Asgharzadeh, MD||Innovation Grants||2015||California|